Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by 2b7f6fabon Nov 04, 2024 7:27pm
206 Views
Post# 36296252

RE:RE:Private Placement

RE:RE:Private Placement

So I’m thinking this recent PP is about just getting through the next month or so and paying down some accounts payable and covering payroll.. I’m also wondering about the listing requirements to get to TSX or NSDQ which some have mentioned on this board over the past few years. TLT has a MC of $64 million cdn. Nearist competitor is like $2 or $3 billion with some money in the bank but their technology doesn’t come near what Theralase has to offer.

Pondering what is BTD worth? How high will this stock climb in the first few days or week if granted BTD? Seriously no one cares how few bucks you got in the kitty if you have smoking hot aassss technology. Currently only approaching 306 million shares fully diluted. Fairly certain stock price will illicit warrant and stock option conversion sufficient to get an uplisting. That there is the cat bird seat.

Best

<< Previous
Bullboard Posts
Next >>